We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MRBK:NASDAQMeridian Corporation Analysis

Data as of 2026-04-18 - not real-time

$20.49

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at $20.49, comfortably above the 20‑day SMA ($19.60) and 50‑day SMA ($19.58), indicating short‑term bullish momentum. RSI sits near 70 (69.5), flagging an overbought condition, while the MACD remains bullish with the line above the signal. Volume is increasing and the price is holding above the identified support of $18.53, though it faces resistance near $21.59. The beta of ~0.75 and 30‑day volatility of 17% suggest moderate price swings relative to the market. On the fundamentals side, MRBK trades at a trailing P/E of 10.8 versus an industry average of 17.7, and offers a 2.73% dividend with a modest 26% payout ratio, underscoring cash‑flow stability. However, the DCF‑derived fair value of $13.76 is well below the current price, implying limited upside and a potential valuation gap.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • RSI approaching overbought levels
  • Price nearing technical resistance
  • Strong dividend provides downside cushion

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable earnings and attractive dividend yield
  • Valuation still above DCF fair value
  • Moderate beta and improving volume trends

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend with low payout ratio
  • Low beta and consistent cash flow generation
  • Potential price correction toward fair value offering upside

Key Metrics & Analysis

Financial Health

Revenue Growth6.70%
Profit Margin19.55%
P/E Ratio10.8
ROE11.76%
ROA0.88%
P/B Ratio1.2
Op. Cash Flow$24.3M
Industry P/E17.7

Technical Analysis

TrendBullish
RSI69.5
Support$18.53
Resistance$21.59
MA 20$19.60
MA 50$19.58
MA 200$16.73
MACDBullish
VolumeIncreasing
Fear & Greed Index90.21

Valuation

Fair Value$13.76
Target Price$22.00
Upside/Downside7.37%
GradeOvervalued
TypeBlend
Dividend Yield2.73%

Risk Assessment

Beta0.85
Volatility17.10%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.